ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

TRVN Trevena Inc

0.407374
-0.00163 (-0.40%)
Last Updated: 10:55:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 10,878
Bid Price 0.385
Ask Price 0.40
News -
Day High 0.409

Low
0.3227

52 Week Range

High
3.28

Day Low 0.3835
Company Name Stock Ticker Symbol Market Type
Trevena Inc TRVN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00163 -0.40% 0.407374 10:55:00
Open Price Low Price High Price Close Price Prev Close
0.3978 0.3835 0.409 0.409
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
49 10,878 $ 0.3978578 $ 4,328 - 0.3227 - 3.28
Last Trade Time Type Quantity Stock Price Currency
11:07:19 2 $ 0.392499 USD

Trevena Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
7.15M 18.32M - 3.13M -40.29M -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Trevena News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TRVN Message Board. Create One! See More Posts on TRVN Message Board See More Message Board Posts

Historical TRVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.3470.41990.32270.375099184,6250.0603717.40%
1 Month0.45560.460.32270.3901159389,231-0.04823-10.59%
3 Months0.61950.700.32270.4564529215,468-0.21213-34.24%
6 Months0.550.76930.32270.5167063153,264-0.14263-25.93%
1 Year0.6253.280.32271.951,001,406-0.21763-34.82%
3 Years43.12555.000.322716.851,131,595-42.72-99.06%
5 Years36.50112.500.322740.121,936,356-36.09-98.88%

Trevena Description

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Your Recent History

Delayed Upgrade Clock